Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial

PrEPVacc is an international, multi-centre, double-blind vaccine study comparing experimental combination vaccine regimens including DNA/AIDSVAX BE and DNA/CN54gp140 with placebo control. Simultaneously, daily oral PrEP is compared for efficacy against daily Truvada in the context of the current PrE...

Descripción completa

Detalles Bibliográficos
Autores principales: Gombe, Ben, Streatfield, Claire, Leal, Lorna, Opio, Solomon, Joseph, Sarah, Weber, Jonathan, Hare, Jonathan, Kaleebu, Pontiano, Serwanga, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632806/
https://www.ncbi.nlm.nih.gov/pubmed/36327320
http://dx.doi.org/10.1371/journal.pone.0275927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632806/
https://www.ncbi.nlm.nih.gov/pubmed/36327320
http://dx.doi.org/10.1371/journal.pone.0275927

Ejemplares similares